BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24090297)

  • 1. Patterns of complementary and alternative medicine use among a group of patients with type 2 diabetes receiving outpatient care in Singapore.
    Fan PE; Chan MF; Chan YL; Koh SL
    Int J Nurs Pract; 2013 Sep; 19 Suppl 3():44-55. PubMed ID: 24090297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary and alternative medicine supplements in patients with diabetes mellitus.
    Fabian E; Töscher S; Elmadfa I; Pieber TR
    Ann Nutr Metab; 2011; 58(2):101-8. PubMed ID: 21474927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization patterns and cost of complementary and alternative medicine compared to conventional medicine in patients with type 2 diabetes mellitus.
    Kim HJ; Chun KH; Kim DJ; Han SJ; Kim YS; Woo JT; Park Y; Nam MS; Baik SH; Ahn KJ; Lee KW
    Diabetes Res Clin Pract; 2011 Jul; 93(1):115-22. PubMed ID: 21524810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of complementary and alternative medicine use by people with type 2 diabetes.
    Chang HY; Wallis M; Tiralongo E
    J Adv Nurs; 2012 Jun; 68(6):1256-66. PubMed ID: 21913959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of complementary and alternative medicine (CAM) practitioners in Singapore.
    Ang SC; Wilkinson JM
    Complement Ther Med; 2013 Feb; 21(1):42-9. PubMed ID: 23374204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-making related to complementary and alternative medicine use by people with Type 2 diabetes: a qualitative study.
    Chang HY; Wallis M; Tiralongo E; Wang HL
    J Clin Nurs; 2012 Nov; 21(21-22):3205-15. PubMed ID: 23083393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes for cancer patients using complementary and alternative medicine.
    Chan A; Tan HL; Ching TH; Tan HC
    Altern Ther Health Med; 2012; 18(1):12-7. PubMed ID: 22516846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates.
    Radwan H; Hasan H; Hamadeh R; Hashim M; AbdulWahid Z; Hassanzadeh Gerashi M; Al Hilali M; Naja F
    BMC Complement Med Ther; 2020 Jul; 20(1):216. PubMed ID: 32650773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine use in multiracial Singapore.
    Lim MK; Sadarangani P; Chan HL; Heng JY
    Complement Ther Med; 2005 Mar; 13(1):16-24. PubMed ID: 15907674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009.
    Patel DN; Low WL; Tan LL; Tan MM; Zhang Q; Low MY; Chan CL; Koh HL
    Clin Toxicol (Phila); 2012 Jul; 50(6):481-9. PubMed ID: 22738039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine (CAM) use and quality of life in people with type 2 diabetes and/or cardiovascular disease.
    Spinks J; Johnston D; Hollingsworth B
    Complement Ther Med; 2014 Feb; 22(1):107-15. PubMed ID: 24559825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine use amongst Palestinian diabetic patients.
    Ali-Shtayeh MS; Jamous RM; Jamous RM
    Complement Ther Clin Pract; 2012 Feb; 18(1):16-21. PubMed ID: 22196568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary and alternative medicine in children with type 1 diabetes mellitus - prevalence, patterns of use, and costs.
    Dannemann K; Hecker W; Haberland H; Herbst A; Galler A; Schäfer T; Brähler E; Kiess W; Kapellen TM
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):228-35. PubMed ID: 18331412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use amongst patients with cardiovascular disease in Singapore.
    Teo TY; Yap J; Shen T; Yeo KK
    BMC Complement Altern Med; 2016 Nov; 16(1):446. PubMed ID: 27825376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.
    Shorofi SA
    Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine use among Turkish diabetes patients.
    Ceylan S; Azal O; Taşlipinar A; Türker T; Açikel CH; Gulec M
    Complement Ther Med; 2009 Apr; 17(2):78-83. PubMed ID: 19185265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of complementary and alternative medicine by patients with cancer: in Turkey.
    Akyol AD; Oz B
    Complement Ther Clin Pract; 2011 Nov; 17(4):230-4. PubMed ID: 21982139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.